Bioxyne has announced that it has made and supplied the nation’s first pharmaceutical-grade cannabis gummies, in what it calls “a significant milestone for Australian pharmaceutical manufacturing”. The gummies (or pastilles) were made under Good Manufacturing Practice (GMP) certification from the Therapeutic Goods Administration by Bioxyne’s wholly-owned subsidiary, Breathe Life Sciences. BLS received deposits on purchase…
Pharmacy supply company Wellnex Life has announced that with its joint venture partner OneLife Botanicals has successfully launched its new medicinal cannabis brand, Wellness Life. Sales began in July with product being prescribed by registered medical professionals under the Special Access Scheme (SAS) in Australia and dispensed by pharmacies. Wellness Life provides patients Australian medicinal…
Medicinal cannabis developer, Bod Science, has released the results of the second pharmacokinetic (PK) study for its Aqua Phase drug delivery system. The system has been developed to make water hating (or lipophilic) drugs, such as cannabinoids (CBD), water soluble. The most recent study, according to the company, demonstrated that Aqua Phase delivers six times…
Robert Iervasi joins SPC Global board SPC Global has announced the appointment of Robert Iervasi to its board, describing Iervasi as “a well-known executive in the FMCG industry [who] brings a wealth of experience and expertise to the SPC Global team.” Iervasi was previously Group CEO at Asahi Beverages, and “played a pivotal role in…
